iRadimed financials
$86.46−0.23%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 | FY23 Dec 31 | FY22 Dec 31 | FY21 Dec 31 | FY20 Dec 31 | FY19 Dec 31 | FY18 Dec 31 | FY17 Dec 31 | FY16 Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $83.8M | $73.2M | $65.6M | $53.3M | $41.8M | $31.7M | $38.5M | $30.4M | $23.1M | $32.5M |
| Gross profit | $64.3M | $56.4M | $50.2M | $41.3M | $32.0M | $23.6M | $29.7M | $23.2M | $17.5M | $26.3M |
| Gross margin | 76.7% | 76.9% | 76.5% | 77.4% | 76.6% | 74.3% | 77.1% | 76.3% | 75.9% | 81.1% |
| Operating income | $26.1M | $22.0M | $20.0M | $15.6M | $9.8M | -$756.1K | $8.6M | $6.0M | $1.3M | $10.9M |
| Net income | $22.5M | $19.2M | $17.2M | $12.8M | $9.3M | $1.4M | $9.6M | $6.3M | $499.8K | $7.2M |
| Net margin | 26.8% | 26.3% | 26.2% | 24.1% | 22.3% | 4.3% | 25.0% | 20.7% | 2.2% | 22.2% |
| Diluted EPS | $1.75 | $1.50 | $1.35 | $1.02 | $0.74 | $0.11 | $0.78 | $0.52 | $0.04 | $0.60 |
| EBITDA | $27.3M | $22.8M | $20.8M | $16.3M | $11.2M | $582.7K | $9.9M | $7.1M | $2.6M | $11.9M |
| Operating cash flow | $24.9M | $25.6M | $13.5M | $10.0M | $11.3M | $5.8M | $10.2M | $7.4M | $3.4M | $9.4M |
| Free cash flow | $16.5M | $16.8M | $5.5M | $8.2M | $10.5M | $5.2M | $9.7M | $7.1M | $2.6M | $7.9M |
| Diluted shares | 12.9M | 12.8M | 12.7M | 12.6M | 12.6M | 12.4M | 12.3M | 12.1M | 11.7M | 12.0M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $51.2M | $52.2M | $49.8M | $58.0M | $62.0M | $50.1M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $501.9K | $1.9M |
| Total debt | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total assets | $108.8M | $98.3M | $92.2M | $85.5M | $82.9M | $71.1M |
| Total liabilities | $14.2M | $11.5M | $20.7M | $11.8M | $10.7M | $9.7M |
| Shareholders' equity | $94.6M | $86.8M | $71.4M | $73.7M | $72.2M | $61.4M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology